PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system
07 avr. 2021 16h01 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C. , April 07, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA’s...
Centro de Enfermedades Raras de PRA lanza Kit de Herramientas para identificar y reducir los riesgos de programas clínicos de enfermedades raras
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
RALEIGH, Carolina del Norte, March 24, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) anunció hoy el lanzamiento de su Kit de Herramientas de Desarrollo de Ensayos Centrados en el...
Centro de Doenças Raras da PRA Lança Kit de Ferramentas para Identificar e Reduzir os Riscos de Programas Clínicos de Doenças Raras
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., March 24, 2021 (GLOBE NEWSWIRE) -- A PRA Health Sciences (NASDAQ: PRAH) anunciou hoje o lançamento do seu Kit de Ferramentas de Desenvolvimento de Ensaios Centrados em Pacientes,...
Pusat untuk Penyakit Jarang Jumpa PRA Melancarkan Kit Alat untuk Mengenal Pasti dan Mengurangkan Risiko kepada Program Klinikal Penyakit Jarang Jumpa
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., March 24, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) mengumumkan pelancaran Kit Alat Pembangunan Percubaan Mengutamakan Pesakit hari ini, kini tersedia untuk penaja...
PRA 산하 Center for Rare Diseases, 희귀병 임상 프로그램 관련 리스크를 식별 및 완화하는 툴킷 출시
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, March 25, 2021 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, (NASDAQ: PRAH))는 임상개발 의뢰자들을 대상으로 Patient-Centric Trial Development Toolkit을 출시했다고 밝혔다. PRA의 Center for Rare...
PRA希少疾患センター、希少疾患臨床プログラムのリスクを特定して軽減するツールキット発表
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
ノースカロライナ州ローリー発 , March 25, 2021 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences) (NASDAQ: PRAH) は本日、希少疾患の臨床開発治験依頼者が患者中心の臨床試験開発ツールキットを利用できるようになったことを発表した。PRA希少疾患センター (Center for Rare Diseases)...
PRA's Center for Rare Diseases führt Toolkit zur Erkennung und Minimierung der Risiken bei klinischen Programmen für seltene Erkrankungen ein
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., March 24, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) hat heute die Einführung seines Patient-Centric Trial Development Toolkit bekanntgegeben, das nun für Sponsoren...
Le Center for Rare Diseases (Centre pour les maladies rares) de PRA lance une boîte à outils afin d'identifier et d'atténuer les risques associés aux programmes cliniques dédiés aux maladies rares
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 24 mars 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ : PRAH) a annoncé aujourd'hui le lancement de sa Boîte à outils de développement d'essais centrés sur le...
PRA 罕見病中心推出了工具包，以識別並緩解罕見病臨床計劃的風險
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
北卡州羅利市, March 24, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) 今天宣佈推出其以患者為本的試驗開發工具包，現已專為罕見疾病的臨床開發贊助商提供。工具包由 PRA 罕見病中心與 PRA 罕見病諮詢委員會 (RDAC)...
PRA罕见疾病中心推出工具包，以识别和降低罕见疾病临床项目风险
24 mars 2021 11h03 HE
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, March 24, 2021 (GLOBE NEWSWIRE) -- PRA Health...